Track topics on Twitter Track topics that are important to you
Maryland Heights, MO, February 28, 2017 --(PR.com)-- The global hemoglobin A1c testing devices market is estimated to reach USD 1.8 Billion in 2020, expanding at a CAGR of 8.4% from 2016 to 2020, due to rise in diabetes and related disorders worldwide.
Browse Hemoglobin A1c Testing Devices Market by Technologies (Boronate Affinity Chromatography, Direct Enzymatic Assay, Immunoassay, Ion-Exchange HPLC, Micro-Optical Detection Method, Capillary Electrophoresis) and End Users (Laboratory Testing Devices, Point-of-Care Testing Devices) 2016-2020 at https://www.ihealthcareanalyst.com/report/hemoglobin-testing-devices-market/
Hemoglobin is a protein inside red blood cells that carries oxygen throughout the body. A hemoglobin test (Hb, Hgb) reveals the level of hemoglobin in a person's blood, helping to diagnose and monitor anemia and polycythemia vera. A Hemoglobin A1c test is an important measure of how well a person with diabetes is controlling their blood glucose level. Hemoglobin A1c test reflects the average blood sugar level of an individual for the past two to three months, which is then used for diabetes management. Rising awareness, higher incidence and prevalence of diabetes and aging of population are significantly contributing to the growth of the hemoglobin A1c testing devices market.
The global hemoglobin A1c testing devices market segmentation is based on technologies (boronate affinity chromatography, direct enzymatic assay, immunoassay, ion-exchange HPLC, micro-optical detection method, capillary electrophoresis) and end users (laboratory testing devices, point-of-care testing devices).
The global hemoglobin A1c testing devices market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020). The global hemoglobin testing devices market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global hemoglobin A1c testing devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.
Major players operating in the global hemoglobin A1c testing devices market and included in this report are Abbott Laboratories, Alere, Inc., Arkray, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., A. Menarini Diagnostics, F. Hoffmann-La Roche Ltd. and Siemens Healthcare.
To request Table of Contents and Sample Pages of this report visit:
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
Contact via Email
Read the full story here: http://www.pr.com/press-release/706944
Press Release Distributed by PR.com
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells. In vertebrates, it is composed of blo...
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity. This can be a drug or biochemical substance or a cell in an organism or organic sample. ...